Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Tofovic

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Renal Failure|June 22, 2001
Renal and metabolic effects of caffeine in obese (fa/fa(cp)), diabetic, hypertensive ZSF1 ratsS P Tofovic, H Kusaka, E K Jackson, et al.
Clinical and Experimental Pharmacology & Physiology|October 7, 2000
Inhibition of cytokine release by and cardiac effects of type IV phosphodiesterase inhibition in early, profound endotoxaemia in vivoS P Tofovic, L C Zacharia, J A Carcillo, et al.
Renal Failure|May 10, 2000
Caffeine augments proteinuria in puromycin-aminonucleoside nephrotic ratsS P Tofovic, B R Rominski, S Bastacky, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
Caffeine potentiates vasodilator-induced renin releaseS P Tofovic, K R Branch, R D Oliver, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
A(1) receptor blockade induces natriuresis with a favorable renal hemodynamic profile in SHHF/Mcc-fa(cp) rats chronically treated with salt and furosemideE K Jackson, C K Kost, W A Herzer, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 1, 2000
Persistent improvement of cardiovascular risk factors in spontaneously hypertensive rats following early short-term captopril treatmentC K Kost, B R Rominski, W A Herzer, et al.
Journal of Clinical Pharmacology|September 2, 1998
Teaching clinical pharmacology and therapeutics: selective for fourth-year medical studentsS P Tofovic, R A Branch, E K Jackson, et al.
Journal of Cardiovascular Pharmacology|November 20, 1998
Effects of type IV phosphodiesterase inhibition on cardiac function in the presence and absence of catecholaminesW A Herzer, N J Thomas, J A Carcillo, et al.
Journal of Hypertension|January 1, 1996
Possible role of adenosine deaminase in vaso-occlusive diseasesE K Jackson, M Koehler, Z Mi, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Renal Failure|June 22, 2001
Renal and metabolic effects of caffeine in obese (fa/fa(cp)), diabetic, hypertensive ZSF1 ratsS P Tofovic, H Kusaka, E K Jackson, et al.
Clinical and Experimental Pharmacology & Physiology|October 7, 2000
Inhibition of cytokine release by and cardiac effects of type IV phosphodiesterase inhibition in early, profound endotoxaemia in vivoS P Tofovic, L C Zacharia, J A Carcillo, et al.
Renal Failure|May 10, 2000
Caffeine augments proteinuria in puromycin-aminonucleoside nephrotic ratsS P Tofovic, B R Rominski, S Bastacky, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
Caffeine potentiates vasodilator-induced renin releaseS P Tofovic, K R Branch, R D Oliver, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
A(1) receptor blockade induces natriuresis with a favorable renal hemodynamic profile in SHHF/Mcc-fa(cp) rats chronically treated with salt and furosemideE K Jackson, C K Kost, W A Herzer, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 1, 2000
Persistent improvement of cardiovascular risk factors in spontaneously hypertensive rats following early short-term captopril treatmentC K Kost, B R Rominski, W A Herzer, et al.
Journal of Clinical Pharmacology|September 2, 1998
Teaching clinical pharmacology and therapeutics: selective for fourth-year medical studentsS P Tofovic, R A Branch, E K Jackson, et al.
Journal of Cardiovascular Pharmacology|November 20, 1998
Effects of type IV phosphodiesterase inhibition on cardiac function in the presence and absence of catecholaminesW A Herzer, N J Thomas, J A Carcillo, et al.
Journal of Hypertension|January 1, 1996
Possible role of adenosine deaminase in vaso-occlusive diseasesE K Jackson, M Koehler, Z Mi, et al.
Pageof 2